Teva Pharmaceuticals USA is the U.S. arm of a company that makes generic and biosimilar medicines. According to its filings, it lobbies Congress on trade and tariff issues, rules and fees that affect generics and biosimilars, supply-chain and drug-shortage concerns, and Medicare and Medicaid payment and prescription-drug negotiation policies. It reported $240,000 across four filings and used Capitol Hill Consulting Group.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRIAN SUTTER
The latest disclosures for this client.
CAPITOL HILL CONSULTING GROUP
Q4CAPITOL HILL CONSULTING GROUP
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CAPITOL HILL CONSULTING GROUP
EMILY ELIZABETH WILKINSON-HOLLAND
CAPITOL HILL CONSULTING GROUP
mr CHRISTOPHER DAVIS
CAPITOL HILL CONSULTING GROUP
KIMBERLEE TRZECIAK
CAPITOL HILL CONSULTING GROUP
CAPITOL HILL CONSULTING GROUP
Q2CAPITOL HILL CONSULTING GROUP
Q1